Establishing a prognostic model based on immune-related genes and identification of BIRC5 as a potential biomarker for lung adenocarcinoma patients

Chia sẻ: _ _ | Ngày: | Loại File: PDF | Số trang:20

Thêm vào BST

Báo xấu

3
lượt xem 2
download

Download Vui lòng tải xuống để xem tài liệu đầy đủ

Lung adenocarcinoma (LUAD) is an extraordinarily malignant tumor, with rapidly increasing morbidity and poor prognosis. Immunotherapy has emerged as a hopeful therapeutic modality for lung adenocarcinoma. Furthermore, a prognostic model (based on immune genes) can fulfill the purpose of early diagnosis and accurate prognostic prediction.

Chủ đề: